Mark S. Schroeder - 02 Feb 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
EVP, President-Diagnostics Lab
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Mark S. Schroeder
Issuer symbol
LH
Transactions as of
02 Feb 2022
Net transactions value
-$76,816
Form type
4
Filing time
04 Feb 2022, 11:15:41 UTC
Previous filing
09 Nov 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +443 +7.1% 6,683 02 Feb 2022 Direct F1
transaction LH Common Stock Tax liability $33,055 -121 -1.8% $273.18 6,562 02 Feb 2022 Direct F2
transaction LH Common Stock Sale $43,761 -161 -2.5% $271.81 6,401 03 Feb 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Restricted Stock Unit Options Exercise $0 -443 -9.3% $0.000000 4,301 02 Feb 2022 Common Stock 443 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F4 The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 2, 2022.
F5 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.